Danske Bank A S Buys New Position in Axon Enterprise, Inc $AXON

Danske Bank A S bought a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 55,220 shares of the biotechnology company’s stock, valued at approximately $39,628,000. Danske Bank A S owned about 0.07% of Axon Enterprise at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Stone House Investment Management LLC purchased a new stake in shares of Axon Enterprise in the 3rd quarter worth $29,000. New Millennium Group LLC purchased a new position in Axon Enterprise during the third quarter valued at $29,000. Darwin Wealth Management LLC purchased a new position in Axon Enterprise during the second quarter valued at $37,000. Root Financial Partners LLC bought a new stake in Axon Enterprise during the third quarter valued at about $34,000. Finally, Elevation Point Wealth Partners LLC bought a new stake in Axon Enterprise during the second quarter valued at about $56,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the sale, the insider directly owned 55,588 shares in the company, valued at approximately $29,740,135.88. This represents a 3.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the transaction, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. The trade was a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 24,832 shares of company stock worth $13,903,398 over the last three months. 4.40% of the stock is owned by company insiders.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $508.41 on Thursday. The firm has a market cap of $40.88 billion, a price-to-earnings ratio of 334.48, a P/E/G ratio of 10.81 and a beta of 1.46. The firm has a fifty day moving average price of $524.40 and a 200 day moving average price of $603.77. Axon Enterprise, Inc has a fifty-two week low of $396.41 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.55. The firm had revenue of $796.72 million for the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business’s revenue was up 38.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.08 earnings per share. As a group, sell-side analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Stronger recurring revenue outlook — analysts and industry write-ups highlight that Axon’s Software & Services segment grew rapidly (~40% y/y in 2025), boosting subscriptions and recurring revenue visibility, which supports higher forward multiples. Axon’s Software & Services Strength in Focus
• Positive Sentiment: Ongoing municipal demand — recent local-government purchases/grants (Decatur $1.97M grant for DPD tech; Yavapai County approves Tasers funding) point to steady device and evidence-management adoption at the municipal level, supporting hardware + services revenue streams. Decatur grant article Yavapai County Tasers
• Positive Sentiment: Institutional interest noted — coverage/mentions (e.g., Baron Capital referenced in investor letters) signal investor interest from growth-focused funds, which can underpin demand for the stock. Baron Capital mention
• Neutral Sentiment: High retail/investor attention — multiple “trending” and comparative performance pieces are circulating, increasing short-term volume and volatility but not signaling a clear directional catalyst. Trending stock write-up
• Neutral Sentiment: Short-interest data appears unreliable — recent reports show “0 shares” and NaN changes, so there’s no actionable signal from the published short-interest figures; treat these data points cautiously.
• Negative Sentiment: Insider sale — Director Erika Nardini sold 198 shares (~$100k) and reduced her stake; while size is modest relative to market cap, insider sales can create short-term negative perception. SEC Form 4
• Negative Sentiment: Recent price weakness and skepticism — coverage (e.g., Forbes) documents a multi-day selloff and questions about whether Axon’s high-growth narrative has paused, which pressures near-term sentiment. Forbes analysis
• Negative Sentiment: Recent intraday/near-term pullbacks reported — some market write-ups note recent declines, adding to short-term volatility risk for momentum-driven holders. Yahoo Markets

Wall Street Analyst Weigh In

AXON has been the topic of several recent research reports. Piper Sandler decreased their price objective on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Robert W. Baird set a $800.00 price objective on Axon Enterprise in a research note on Wednesday, February 25th. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Finally, Citigroup reiterated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $762.93.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.